This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Biological and Chemical Indicators Market

Market Insights on Biological and Chemical Indicators covering sales outlook, demand forecast & up-to-date key trends

Biological and Chemical Indicators Market By Sterilization Type (Thermal Sterilization, Chemical Sterilization and Radiation Sterilization), Indicator Class (Biological Indicators, Chemical Indicators and Enzyme Indicators) & Region - Forecast 2022 - 2030

Biological and Chemical Indicators Market Snapshot (2022-2030)

[269 Pages] The global biological and chemical indicators market is set to record a market value of US$ 457.8 Mn in the year 2022 with an estimated growth rate of 7.2% CAGR which indicates a positive market growth over the forecast period.

Data Points

Market Insights

Market Value 2022

USD 457.8 Mn

Market Value 2030

USD 801.4 Mn

CAGR 2022-2030

7.2%

Key Players

The key players are 3M Company, Steris Plc., Getinge AB, Thermo Fisher Scientific Inc., Mesa Labs, Inc., McKesson Medical-Surgical Inc., Crosstex International, Inc. (Cantel Medical Corp.), Propper Manufacturing Co., Inc., Liofilchem S.r.l., Terragene S.A., GKE-GmbH

Protak Scientific Ltd., Siltex Australia, Andersen Products, Inc., ParaSure Limited, Excelsior Scientific

Share of Top 5 Countries

61.4%

As projected by Future Market Insights, the biological indicators by indicator class are estimated to see a market value of US$ 393.2 Mn, that show more than half of the total biological and chemical indicators market, in the year 2022.

Increasing adoption rate of universal sterilization indicators, increasing advanced product development, rising commercialization of parenteral therapeutics, diagnosing disease, and development of In-house sterilization monitoring solution are the primary factors boosting the development of the biological and chemical indicators market.

Moreover, the number of COVID-19 cases in pandemic creates unmet demand for research based chemical and especially biological indicator. This gave huge growth opportunities for the numerous players in this market.

Biological and chemical indicators market holds nearly 10.4% market value share of the US$ 4.1 Bn sterilization market in 2021. In addition, collaborative efforts and initiatives to do efficient workflow and emerging trend of exploring next-generation techniques is expected to lead to rapid growth in the biological and chemical indicators market.

Customize this Report

Let us know your requirement to get
100% FREE customization

How The Market Progressed Till June 2022?

Particulars

Details

H1, 2021

7.28%

H1, 2022 Projected

7.28%

H1, 2022 Outlook

7.28%

BPS Change - H1, 2022 (O) – H1, 2022 (P)

(-) 10 ↓

BPS Change – H1, 2022 (O) – H1, 2021

(-) 13 ↓

According to FMI, the biological and chemical indicators market will show dip in the BPS change by nearly 13 basis point share (BPS) in H1-2022 (O) on comparison with H1-2021. Furthermore, variation in BPS change is also observed on comparing H1-2022 outlook and H1-2022 projected period by nearly 10 BPS.

The shortcomings of rapid biological indicators include the fact that under unfavorable conditions such as temperature variation, the period available to detect fluorescence is not adequate, thus presenting with low output than expected, and this factor is associated with several disadvantages to the market.

The under developed regions have limitations in-terms of the resources and capabilities for sterilization procedures and monitoring, which contributes to the BPS value reduction.

The growth rates and development possibilities of the global biological and chemical indicators market have been analyzed by FMI. The market is subject to be influence by quality assessment, regulations, and the impact of macro and industrial variables.

The increased volumes of surgery after the advent of the COVID-19 pandemic, as well as the rising rate of hospital acquired infections, are the key driving factors promoting the adoption of biological and chemical indicators.

2015-2021 Biological and Chemical Indicators Market Demand Outlook Compared to 2022-2030 forecast

Rising concern for safety and hygiene, high burden of surgeries and increasing unmet demand due to Covid-19 pandemic are some of the major drivers for biological and chemical indicators market.

Growing risk of infections during surgeries and hospital acquired infections create huge demand for safety and hygiene in sterile production process. Numerous hygiene awareness programs in various regions to promote the use of sterile instruments and equipment’s will create opportunities in the biological and chemical indicators based market in near future.

For Instance, the Georgia Environmental Protection Division (EPD) and U.S. Environmental Protection Agency (EPA) gave joint protocol to provide support by increasing the production at sterilization facilities in the cities of Covington and Madison during COVID-19 as there was high demand and short supply for sterile medical equipment.

Biological and Chemical Indicators Market Download Report Brochure

Moreover, surgical care is essential to manage diverse health conditions, such as injuries, malignancy, infections and cardiovascular diseases. Increase in the number of surgical procedures will have a direct impact on the sale of biological and chemical indicators. According to a WHO study, in 2020, around 310 million surgical procedures were used to address the burden of different diseases for global population.

Considering this, FMI expects the global biological and chemical indicators market to grow at CAGR of 7.2% through 2030.

Which Factors Are Restraining Demand for Biological and Chemical Indicators?

Inconvenience and long waiting time for results, sub-standard sterilization practices and increasing adoption of disposable biological and chemical indicators are the key factors restraining the market growth over the forecast period.

The classical sterilization indicators such as biological indicators takes longer period of time, about 7 days to show results. In addition, chemical indicators can give false positive results and are generally not recommended by the healthcare regulatory agencies. This disadvantage of classic sterilization indicators are expected to hamper the adoption rate of the products.

In addition, under developed regions have limitations in-terms of the resources and capabilities for sterilization procedures and monitoring. In the non-regulated market, several professionals rely on non-validated sterilization procedures or violate the standard sterilization protocols. Such practices are expected to reduce the use of sterilization indicators during sterilization procedures which is a major factor restraining the market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

What Makes the U.S. a Large Market for Biological and chemical indicators?

The U.S. is estimated to account for around 91.1% of the North America biological and chemical indicators market in 2022.

The dominant share of U.S. can mainly be owing to the launch of technologically advanced products, regulatory stringency and compliance and increasing discretionary funding for cancer research in the country. With advancements in manufacturing and digitalization, healthcare professionals expect customized sterilization indicators solutions in the sterilization monitoring operations. Several innovative biological and chemical indicators supplier in the U.S. market are offering customized services of sterilization indicators specific to the need of the end users. This driver is expected to become competitive-edge for the players in the market.

For example, Sterilization Indicators contract manufacturer (OME) and Propper Manufacturing Co., Inc., U.S., offers multiple packaging form and indicators as per customization needs to healthcare end users. These includes cost-effective, environmental friendly and tailored to specific customer needs along with maintaining ISO and FDA compliance.

Additionally, regulatory authorities of regulated markets such as U.S. and ISO regions have issued separate guidelines on the regulatory requirements of the sterilization validation procedures for the compliance of the sterilization procedures. These regulatory stringency is expected to increase the demand of biological and chemical indicators across the global and U.S market.

Why is Germany Considered a Lucrative Biological and chemical indicators Market?

Germany is estimated to account for 17.5% of the Europe biological and chemical indicators market in 2022.

Germany is expected to lead the market owing to technological advancements, rise in incidence of COVID-19 and huge research and development facilities.

German companies have strong focus and continuous investments on research and technological advancement for the development and commercialization of rapid sterilization monitoring products. These are expected to raise the adoption of biological indicators due to their high speed and high efficacy features. This factor drive the demand for the market.

For instance, Protak Scientific Ltd., a Europe-based innovative startup, invented and commercialized the new class of sterilization indicators known as Enzyme Indicators. The product use a thermostable Adenylate kinase (tAK) enzyme isolated from thermophilic bacteria found in hot springs (Sulpholobus acidocaldarius).

What are the Factors Fueling the Demand for Biological and chemical indicators in China?

The biological and chemical indicators market in China is estimated to be worth US$ 32.7 Mn in 2022 in the global market.

Increasing community infections and hospital acquired infections are creating opportunities for biological and chemical indicators in Chinese market.

Biopharmaceutical industry is actively engaged in the development of novel biologics and sensitive products. Among the newly commercialized biologics, majority of therapeutics are formulated in the parenteral dosage form. This increase in parenteral dosage manufacturing volume across the biopharmaceutical industry is expected to fuel the growth of biological and chemical indicators market in china.

How will the Biological and chemical indicators Market Expand across India?

In 2022, the demand for biological and chemical indicators in India is expected to grow at market share of 72.0%. Outsourcing of biopharma research is done extensively in emerging countries like India. Clinical trial partnership of various key players with emerging companies to speed up the clinical trial process is on rise. The partnership is expected to help both companies to explore best results in less time. Such partnership agreement amongst players will help in gaining traction in Indian market.

Category-wise Insights

Demand for Thermal Sterilization continue gaining Traction

By sterilization type, thermal sterilization is anticipated to hold the largest share of 69.4% in 2022. This is due to significant preference to the steam heat sterilization over other sterilization types owing to high possibility of toxicity, handling risk and environmental pollution associated with other sterilization types. Thermal sterilization uses the thermal liability of a microorganism to prevent its growth. Hence a growing popularity and demand for this segment makes it the leading one.

Why Biological Indicators will hold the most of the market share?

By indicator class, biological indicators will lead the market and is projected to account for 85.8% of the total market revenue share in 2022.

Biological indicators segment is widely dominated due to regulatory recommendation to use biological indicators instead of chemical ones to achieve high standard in sterility assurance. In addition, increasing commercialization of user friendly biological indicators with rapid sterilization validation compliance is a key factor in rising biological indicators adoption rate.

Demand for Self-Contained BI continue gaining Traction by form.

By Form, Self-Contained BI is anticipated to hold the largest share of 42.0% in 2022. The high flexibility and efficiency of self-contained BI to deliver rapid results and overall increase in operational efficiency lead this segment to hold the highest share.

Why Biopharma Industry projected maximum growth in the Biological and chemical indicators Market?

By End User, biopharma industry is anticipated to hold nearly half of the global market share in terms of revenue in 2022.

Among all end users, biopharma industry segment is a leading segment which is then followed by hospitals. The rising parenteral formulation including new (biologics/synthetics) and generic formulation and stringent regulatory compliance requirements of sterilization validation is rising the demand of sterilization indicators in biopharmaceuticals industry.

Competitive Landscape

Companies operating in the biological and chemical indicators market are fragmented by nature, with a presence of few players. These players are involved in a number of strategic alliances. The agreement and system automation accelerates the manufacturer’s strategy to capitalize on the market share and capture the significant share of market. Some of the recent instances include:

  • In 2020, The Thermo Fisher Scientific, Inc. announced the acquisition of QIAGEN N.V at approximately US$ 11.5 billion.
  • In July 2020, 3M company announced Attest Mini Auto-reader 490M, a 24-minute in-house sterilization monitoring solution, the technology designed for the dental professionals use.
Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Scope of the Report

Attribute

Details

Forecast Period

2015-2021

Historical Data Available for

2022-2030

Market Analysis

USD Million for Value

Key Countries Covered

US, Canada, Brazil, Mexico, Argentina, Germany, U.K., France, Italy, Spain, Russia, Nordic, China, Japan, South Korea, India, Indonesia, Malaysia, Thailand, Australia, New Zealand, GCC Countries, South Africa, Turkey

Key Segments Covered

Sterilization Type, Indicator Class, Packaging Form, End User and Region

Key Companies Profiled

  • The 3M Company
  • Steris Plc.
  • Thermo Fisher Scientific, Inc.
  • Mesa Labs, Inc.
  • McKesson Medical-Surgical Inc.
  • Crosstex International, Inc.
  • Propper Manufacturing Co., Inc.
  • Terragene S.A.
  • Andersen Products, Inc.
  • Getinge AB
  • GKE-GmbH
  • Liofilchem S.r.l. /li>
  • Protak Scientific Ltd.
  • ParaSure Limited
  • Excelsior Scientific
  • Siltex Australia Pvt. Ltd.

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Biological and chemical indicators Market by Category

By Sterilization Type

  • Thermal Sterilization
    • Steam Heat
    • Dry Heat
  • Chemical Sterilization
    • Ethylene Oxide
    • Hydrogen Peroxide
    • Formaldehyde
  • Radiation Sterilization

By Indicator Class

  • Biological Indicators
    • Geobacillus stearothermophilus (GS) Spores
    • Bacillus atrophaeus (BA) Spores
    • Others
  • Chemical Indicators
    • Class 1 (Process)
    • Class 4 (Multi-Variable)
    • Class 2 (Specific-Use)
    • Class 3 (Single-Variable)
    • Class 5 (Integrating)
    • Class 6 (Cycle Verification)
  • Enzyme Indicators

By Packaging Form

  • Self-Contained BI
  • Spore Suspension BI
  • Strip and Disc BI
  • Strip and Disc CI
  • Others

By End User

  • Biopharma Industry
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Labs
  • Research Lab

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle-East & Africa

Frequently Asked Questions

The global biological and chemical indicators market is worth US$ 427.5 Mn in 2021 and is set to expand 1.8X over the forecast years owing to the commercialization of parenteral therapeutics together with the rapid traction in research.

The biological and chemical indicators market is expected to reach US$ 801.4 Mn by the end of 2030 with sales revenue expected to register CAGR of 7.2% over the forecast period.

North America currently holds the largest market share in the biological and chemical indicators and is estimated to hold nearly 40.3% revenue share in 2022 of the global market with U.S. being the leading contributor with a market value of US$ 169.4 Mn in 2022.

Demand of biological and chemical indicators market is expected to register growth in Europe with CAGR of 7.3% over the forecast period.

The biological and chemical indicators in China is likely to observe growth with an impressive growth rate of 6.7% in 2022. The market in China is driven by the growing demand due to rising COVID-19 cases, increasing number of local players and growing technological advancements.

Development of rapid in-house sterilization monitoring solution, customized design and manufacturing fueling the product demand and emergence of new technology (enzyme indicator) for sterilization validation are some of the key trends driving sales of biological and chemical indicators market across the globe.

US, China, Japan, Germany, and U.K., are the top 5 countries that are driving the demand for biological and chemical indicators market.

Leading companies of biological and chemical indicators are 3M Company, Steris Plc., Getinge AB, Thermo Fisher Scientific Inc., Mesa Labs, Inc., McKesson Medical-Surgical Inc., Crosstex International, Inc. (Cantel Medical Corp.), Propper Manufacturing Co., Inc., Liofilchem S.r.l., Terragene S.A., GKE-GmbH, Protak Scientific Ltd., Siltex Australia, Andersen Products, Inc., ParaSure Limited and Excelsior Scientific

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Market Background

    4.1. COVID19 Crisis Analysis

        4.1.1. Current COVID19 Statistics and Probable Future Impact

        4.1.2. Current GDP Projection and Probable Impact

        4.1.3. Current Economic Projection as compared to 2008 Economic analysis

        4.1.4. COVID19 and Impact Analysis

            4.1.4.1. Revenue By Sterilization Type

            4.1.4.2. Revenue By Indicator Class

            4.1.4.3. Revenue By Country

        4.1.5. 2020 Market Scenario

        4.1.6. Quarter by Quarter Forecast

        4.1.7. Projected recovery Quarter

        4.1.8. Recovery Scenario – Short term, Midterm and Long Term Impact

    4.2. Macro-Economic Factors

        4.2.1. Global GDP Growth Outlook

        4.2.2. Global Healthcare Outlook

    4.3. Forecast Factors - Relevance & Impact

        4.3.1. Historical Growth of Top Players 

        4.3.2. Technological Advancement

        4.3.3. Adoption of Biological and Chemical Indicators

        4.3.4. Cost of Biological and Chemical Indicators

        4.3.5. Increasing Epidemic of Infections 

    4.4. Market Dynamics

        4.4.1. Drivers

        4.4.2. Restraints

        4.4.3. Opportunities 

5. Market Context

    5.1. Product USPs/ Features

    5.2. List of Branded and OEM Products  

    5.3. Latest Industry Deals/A&M

    5.4. Product  Adoption / Indicator Class Analysis

    5.5. Regulatory Scenario

    5.6. Sterilization Process Volume Analysis for Top Countries

6. Global Biological and Chemical Indicators Market Volume (Units) Analysis 2015-2021 and Forecast, 2022-2030

    6.1. Historical Market Volume (Units) Analysis, 2015-2021

    6.2. Current and Future Market Volume (Units) Projections, 2022-2030

        6.2.1. Y-o-Y Growth Trend Analysis

7. Global Biological and Chemical Indicators Market - Pricing Analysis

    7.1. Regional Pricing Analysis By Sterilization Type

    7.2. Pricing Break-up

        7.2.1. Manufacturer Level Pricing

        7.2.2. Distributor Level Pricing

    7.3. Global Average Pricing Analysis Benchmark

8. Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis 2015-2021 and Forecast, 2022-2030

    8.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2030

        8.2.1. Y-o-Y Growth Trend Analysis

        8.2.2. Opportunity Analysis, 2022-2030

9. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By Sterilization Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis By Sterilization Type, 2015–2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sterilization Type, 2022-2030

        9.3.1. Thermal Sterilization

                9.3.1.1.1. Steam Heat 

                9.3.1.1.2. Dry Heat

        9.3.2. Chemical Sterilization

                9.3.2.1.1. Ethylene Oxide 

                9.3.2.1.2. Hydrogen Peroxide 

                9.3.2.1.3. Formaldehyde

        9.3.3. Radiation Sterilization

    9.4. Market Attractiveness Analysis By Sterilization Type

10. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By Indicator Class

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis By Indicator Class, 2015–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indicator Class, 2022-2030

        10.3.1. Biological Indicators

                10.3.1.1.1. Bacillus atrophaeus (BA) Spores

                10.3.1.1.2. Geobacillus stearothermophilus (GS) Spores

                10.3.1.1.3. Others

        10.3.2. Chemical Indicators

                10.3.2.1.1. Class 1 (Process)

                10.3.2.1.2. Class 4 (Multi-Variable)

                10.3.2.1.3. Class 2 (Specific-Use)

                10.3.2.1.4. Class 3 (Single-Variable)

                10.3.2.1.5. Class 5 (Integrating)

                10.3.2.1.6. Class 6 (Cycle Verification)

        10.3.3. Enzyme Indicators

    10.4. Market Attractiveness Analysis By Indicator Class

11. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By Packaging Form

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis By Packaging Form, 2015–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Packaging Form, 2022-2030

        11.3.1. Self-Contained BI

        11.3.2. Spore Suspension BI

        11.3.3. Strip and Disc BI

        11.3.4. Strip and Disc CI

        11.3.5. Others 

    11.4. Market Attractiveness Analysis By End User

12. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, By End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015–2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2030

        12.3.1. Biopharma Industry

        12.3.2. Hospitals

        12.3.3. Clinics

        12.3.4. Ambulatory Surgical Centres

        12.3.5. Diagnostic Labs

        12.3.6. Research Lab

    12.4. Market Attractiveness Analysis By End User

13. Global Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030, by Region

    13.1. Introduction / Key Findings

    13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015–2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2030

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. East Asia

        13.3.5. South Asia Pacific

        13.3.6. Middle East and Africa (MEA)

    13.4. Market Attractiveness Analysis By Region

14. North America Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        14.3.1.  By Country

            14.3.1.1. U.S.

            14.3.1.2. Canada

        14.3.2. By Sterilization Type

        14.3.3. By Indicator Class

        14.3.4. By Packaging Form 

        14.3.5. By End User

    14.4. Market Attractiveness Analysis

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Latin America Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        15.3.1. By Country

            15.3.1.1. Brazil

            15.3.1.2. Mexico

            15.3.1.3. Argentina

            15.3.1.4. Rest of Latin America

        15.3.2. By Sterilization Type

        15.3.3. By Indicator Class

        15.3.4. By Packaging Form 

        15.3.5. By End User

    15.4. Market Attractiveness Analysis

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Europe Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        16.3.1. By Country

            16.3.1.1. Germany

            16.3.1.2. Italy

            16.3.1.3. France

            16.3.1.4. U.K.

            16.3.1.5. Spain

            16.3.1.6. BENELUX

            16.3.1.7. Russia

            16.3.1.8. Rest of Europe

        16.3.2. By Sterilization Type

        16.3.3. By Indicator Class

        16.3.4. By Packaging Form 

        16.3.5. By End User

    16.4. Market Attractiveness Analysis

    16.5. Key Market Participants - Intensity Mapping

    16.6. Drivers and Restraints - Impact Analysis

17. South Asia Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        17.3.1. By Country

            17.3.1.1. India 

            17.3.1.2. Thailand

            17.3.1.3. Indonesia

            17.3.1.4. Malaysia

            17.3.1.5. Rest of South Asia 

        17.3.2. By Sterilization Type

        17.3.3. By Indicator Class

        17.3.4. By Packaging Form 

        17.3.5. By End User

    17.4. Market Attractiveness Analysis

    17.5. Key Market Participants - Intensity Mapping

    17.6. Drivers and Restraints - Impact Analysis

18. East Asia Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        18.3.1. By Country

            18.3.1.1. China

            18.3.1.2. Japan

            18.3.1.3. South Korea

        18.3.2. By Sterilization Type

        18.3.3. By Indicator Class

        18.3.4. By Packaging Form 

        18.3.5. By End User

    18.4. Market Attractiveness Analysis

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

19. Oceania Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        19.3.1. By Country

            19.3.1.1. Australia

            19.3.1.2. New Zealand

        19.3.2. By Sterilization Type

        19.3.3. By Indicator Class

        19.3.4. By Packaging Form 

        19.3.5. By End User

    19.4. Market Attractiveness Analysis

    19.5. Key Market Participants - Intensity Mapping

    19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Biological and Chemical Indicators Market Analysis 2015-2021 and Forecast 2022-2030

    20.1. Introduction

    20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015–2021

    20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022-2030

        20.3.1. By Country

            20.3.1.1. GCC Countries

            20.3.1.2. Turkey

            20.3.1.3. South Africa

            20.3.1.4. Rest of Middle East and Africa

        20.3.2. By Sterilization Type

        20.3.3. By Indicator Class

        20.3.4. By Packaging Form 

        20.3.5. By End User

    20.4. Market Attractiveness Analysis

    20.5. Key Market Participants - Intensity Mapping

    20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Biological and Chemical Indicators Market Analysis 2022 & 2030

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis, By Key Countries

        21.1.2. Global Vs. Country Growth Comparison

    21.2. U.S. Biological and Chemical Indicators Market Analysis

        21.2.1. By Sterilization Type

        21.2.2. By Indicator Class

        21.2.3. By Packaging Form 

        21.2.4. By End User

    21.3. Canada Biological and Chemical Indicators Market Analysis

        21.3.1. By Sterilization Type

        21.3.2. By Indicator Class

        21.3.3. By Packaging Form 

        21.3.4. By End User

    21.4. Mexico Biological and Chemical Indicators Market Analysis

        21.4.1. By Sterilization Type

        21.4.2. By Indicator Class

        21.4.3. By Packaging Form 

        21.4.4. By End User

    21.5. Brazil Biological and Chemical Indicators Market Analysis

        21.5.1. By Sterilization Type

        21.5.2. By Indicator Class

        21.5.3. By Packaging Form 

        21.5.4. By End User

    21.6. U.K. Biological and Chemical Indicators Market Analysis

        21.6.1. By Sterilization Type

        21.6.2. By Indicator Class

        21.6.3. By Packaging Form 

        21.6.4. By End User

    21.7. Germany Biological and Chemical Indicators Market Analysis

        21.7.1. By Sterilization Type

        21.7.2. By Indicator Class

        21.7.3. By Packaging Form 

        21.7.4. By End User

    21.8. France Biological and Chemical Indicators Market Analysis

        21.8.1. By Sterilization Type

        21.8.2. By Indicator Class

        21.8.3. By Packaging Form 

        21.8.4. By End User

    21.9. Italy Biological and Chemical Indicators Market Analysis

        21.9.1. By Sterilization Type

        21.9.2. By Indicator Class

        21.9.3. By Packaging Form 

        21.9.4. By End User

    21.10. Spain Biological and Chemical Indicators Market Analysis

        21.10.1. By Sterilization Type

        21.10.2. By Indicator Class

        21.10.3. By Packaging Form 

        21.10.4. By End User

    21.11. Russia Biological and Chemical Indicators Market Analysis

        21.11.1. By Sterilization Type

        21.11.2. By Indicator Class

        21.11.3. By Packaging Form 

        21.11.4. By End User

    21.12. China Biological and Chemical Indicators Market Analysis

        21.12.1. By Sterilization Type

        21.12.2. By Indicator Class

        21.12.3. By Packaging Form 

        21.12.4. By End User

    21.13. Japan Biological and Chemical Indicators Market Analysis

        21.13.1. By Sterilization Type

        21.13.2. By Indicator Class

        21.13.3. By Packaging Form 

        21.13.4. By End User

    21.14. South Korea Biological and Chemical Indicators Market Analysis

        21.14.1. By Sterilization Type

        21.14.2. By Indicator Class

        21.14.3. By Packaging Form 

        21.14.4. By End User

    21.15. India Biological and Chemical Indicators Market Analysis

        21.15.1. By Sterilization Type

        21.15.2. By Indicator Class

        21.15.3. By Packaging Form 

        21.15.4. By End User

    21.16. ASEAN Biological and Chemical Indicators Market Analysis

        21.16.1. By Sterilization Type

        21.16.2. By Indicator Class

        21.16.3. By Packaging Form 

        21.16.4. By End User

    21.17. Australia Biological and Chemical Indicators Market Analysis

        21.17.1. By Sterilization Type

        21.17.2. By Indicator Class

        21.17.3. By Packaging Form 

        21.17.4. By End User

    21.18. New Zealand Biological and Chemical Indicators Market Analysis

        21.18.1. By Sterilization Type

        21.18.2. By Indicator Class

        21.18.3. By Packaging Form 

        21.18.4. By End User

    21.19. GCC Countries Biological and Chemical Indicators Market Analysis

        21.19.1. By Sterilization Type

        21.19.2. By Indicator Class

        21.19.3. By Packaging Form 

        21.19.4. By End User

    21.20. Turkey Biological and Chemical Indicators Market Analysis

        21.20.1. By Sterilization Type

        21.20.2. By Indicator Class

        21.20.3. By Packaging Form 

        21.20.4. By End User

    21.21. South Africa Biological and Chemical Indicators Market Analysis

        21.21.1. By Sterilization Type

        21.21.2. By Indicator Class

        21.21.3. By Packaging Form 

        21.21.4. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies 

    22.2. Market Share Analysis of Top Players

    22.3. Market Presence Analysis

        22.3.1. Regional Footprint by Players

        22.3.2. Product Foot print by Players

        22.3.3. Channel Foot Print by Players

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Competition Deep Dive (Tentative List)

        23.3.1. The 3M Company  

            23.3.1.1. Overview

            23.3.1.2. Product  Portfolio

            23.3.1.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.1.4. Sales Footprint

            23.3.1.5. Strategy Overview

                23.3.1.5.1. Marketing Strategy

                23.3.1.5.2. Product Strategy

                23.3.1.5.3. Channel Strategy

        23.3.2. Steris Plc.

            23.3.2.1. Overview

            23.3.2.2. Product  Portfolio

            23.3.2.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.2.4. Sales Footprint

            23.3.2.5. Strategy Overview

                23.3.2.5.1. Marketing Strategy

                23.3.2.5.2. Product Strategy

                23.3.2.5.3. Channel Strategy

        23.3.3. Getinge AB

            23.3.3.1. Overview

            23.3.3.2. Product  Portfolio

            23.3.3.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.3.4. Sales Footprint

            23.3.3.5. Strategy Overview

                23.3.3.5.1. Marketing Strategy

                23.3.3.5.2. Product Strategy

                23.3.3.5.3. Channel Strategy

        23.3.4. Crosstex International, Inc.

            23.3.4.1. Overview

            23.3.4.2. Product  Portfolio

            23.3.4.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.4.4. Sales Footprint

            23.3.4.5. Strategy Overview

                23.3.4.5.1. Marketing Strategy

                23.3.4.5.2. Product Strategy

                23.3.4.5.3. Channel Strategy

        23.3.5. McKesson Medical-Surgical Inc.

            23.3.5.1. Overview

            23.3.5.2. Product  Portfolio

            23.3.5.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.5.4. Sales Footprint

            23.3.5.5. Strategy Overview

                23.3.5.5.1. Marketing Strategy

                23.3.5.5.2. Product Strategy

                23.3.5.5.3. Channel Strategy

        23.3.6. Mesa Labs, Inc

            23.3.6.1. Overview

            23.3.6.2. Product  Portfolio

            23.3.6.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.6.4. Sales Footprint

            23.3.6.5. Strategy Overview

                23.3.6.5.1. Marketing Strategy

                23.3.6.5.2. Product Strategy

                23.3.6.5.3. Channel Strategy

        23.3.7. Siltex Australia

            23.3.7.1. Overview

            23.3.7.2. Product  Portfolio

            23.3.7.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.7.4. Sales Footprint

            23.3.7.5. Strategy Overview

                23.3.7.5.1. Marketing Strategy

                23.3.7.5.2. Product Strategy

                23.3.7.5.3. Channel Strategy

        23.3.8. Thermo Fisher Scientific

            23.3.8.1. Overview

            23.3.8.2. Product  Portfolio

            23.3.8.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.8.4. Sales Footprint

            23.3.8.5. Strategy Overview

                23.3.8.5.1. Marketing Strategy

                23.3.8.5.2. Product Strategy

                23.3.8.5.3. Channel Strategy

        23.3.9. Andersen Products, Inc.

            23.3.9.1. Overview

            23.3.9.2. Product  Portfolio

            23.3.9.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.9.4. Sales Footprint

            23.3.9.5. Strategy Overview

                23.3.9.5.1. Marketing Strategy

                23.3.9.5.2. Product Strategy

                23.3.9.5.3. Channel Strategy

        23.3.10. GKE-GmbH

            23.3.10.1. Overview

            23.3.10.2. Product  Portfolio

            23.3.10.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.10.4. Sales Footprint

            23.3.10.5. Strategy Overview

                23.3.10.5.1. Marketing Strategy

                23.3.10.5.2. Product Strategy

                23.3.10.5.3. Channel Strategy

        23.3.11. Terragene S.A.

            23.3.11.1. Overview

            23.3.11.2. Product  Portfolio

            23.3.11.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.11.4. Sales Footprint

            23.3.11.5. Strategy Overview

                23.3.11.5.1. Marketing Strategy

                23.3.11.5.2. Product Strategy

                23.3.11.5.3. Channel Strategy

        23.3.12. ParaSure Limited

            23.3.12.1. Overview

            23.3.12.2. Product  Portfolio

            23.3.12.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.12.4. Sales Footprint

            23.3.12.5. Strategy Overview

                23.3.12.5.1. Marketing Strategy

                23.3.12.5.2. Product Strategy

                23.3.12.5.3. Channel Strategy

        23.3.13. Propper Manufacturing Co., Inc.

            23.3.13.1. Overview

            23.3.13.2. Product  Portfolio

            23.3.13.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.13.4. Sales Footprint

            23.3.13.5. Strategy Overview

                23.3.13.5.1. Marketing Strategy

                23.3.13.5.2. Product Strategy

                23.3.13.5.3. Channel Strategy

        23.3.14. Protak Scientific Ltd.

            23.3.14.1. Overview

            23.3.14.2. Product  Portfolio

            23.3.14.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.14.4. Sales Footprint

            23.3.14.5. Strategy Overview

                23.3.14.5.1. Marketing Strategy

                23.3.14.5.2. Product Strategy

                23.3.14.5.3. Channel Strategy

        23.3.15. Liofilchem S.r.l.

            23.3.15.1. Overview

            23.3.15.2. Product  Portfolio

            23.3.15.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.15.4. Sales Footprint

            23.3.15.5. Strategy Overview

                23.3.15.5.1. Marketing Strategy

                23.3.15.5.2. Product Strategy

                23.3.15.5.3. Channel Strategy

        23.3.16. Excelsior Scientific

            23.3.16.1. Overview

            23.3.16.2. Product  Portfolio

            23.3.16.3. Profitability by Market Segments (Product/Channel/Region)

            23.3.16.4. Sales Footprint

            23.3.16.5. Strategy Overview

                23.3.16.5.1. Marketing Strategy

                23.3.16.5.2. Product Strategy

                23.3.16.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Biological and Chemical Indicators Market Volume (‘000 Units) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 02: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 03: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 04: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 05: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 06: Global Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Region

Table 07: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 08: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 09: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 10: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 11: North America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 12: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 13: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 14: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 15: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 16: Latin America Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 17: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 18: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 19: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 20: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 21: Europe Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 22: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 23: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 24: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 25: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 26: South Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 27: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 28: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 29: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 30: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 31: East Asia Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 32: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 33: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 34: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 35: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 36: Oceania Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Table 37: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Country

Table 38: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Sterilization Type

Table 39: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Indicator Class

Table 40: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By Packaging Form

Table 41: MEA Biological and Chemical Indicators Market Value (US$ Mn) Analysis and Opportunity Assessment 2015–2030, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Biological and Chemical Indicators Market Volume (Mn Units) Analysis, 2015-2021

Figure 02: Global Biological and Chemical Indicators Market Volume Forecast (Mn Units), 2022-2030

Figure 03: Global Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 04: Global Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 05: Global Biological and Chemical Indicators Market Absolute $ Opportunity, 2022 - 2030

Figure 06: Global Biological and Chemical Indicators Market Share Analysis (%), By Sterilization Type, 2022-2030

Figure 07: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Sterilization Type, 2022-2030

Figure 08: Global Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 09: Global Biological and Chemical Indicators Market Share Analysis (%), By Indicator Class, 2022-2030

Figure 10: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Indicator Class, 2022-2030

Figure 11: Global Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 12: Global Biological and Chemical Indicators Market Share Analysis (%), By Packaging Form, 2022-2030

Figure 13: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Packaging Form, 2022-2030

Figure 14: Global Biological and Chemical Indicators Market Attractiveness Analysis by Size, 2022-2030

Figure 15: Global Biological and Chemical Indicators Market Share Analysis (%), By End User, 2022-2030

Figure 16: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By End User, 2022-2030

Figure 17: Global Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 18: Global Biological and Chemical Indicators Market Share Analysis (%), By Region, 2022-2030

Figure 19: Global Biological and Chemical Indicators Market Y-o-Y Analysis (%), By Region, 2022-2030

Figure 20: Global Biological and Chemical Indicators Market Attractiveness Analysis by Region, 2022-2030

Figure 21: North America Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 22: North America Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 23: North America Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 24: North America Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 25: North America Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)

Figure 26: North America Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 27: North America Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 28: North America Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 29: North America Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 30: North America Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030

Figure 31: North America Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 32: North America Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030

Figure 33: Latin America Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 34: Latin America Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 35: Latin America Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 36: Latin America Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 37: Latin America Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)

Figure 38: Latin America Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 39: Latin America Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 40: Latin America Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 41: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 42: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030

Figure 43: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 44: Latin America Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030

Figure 45: Europe Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 46: Europe Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 47: Europe Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 48: Europe Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 49: Europe Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)

Figure 50: Europe Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 51: Europe Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 52: Europe Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 53: Europe Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 54: Europe Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030

Figure 55: Europe Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 56: Europe Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030

Figure 57: South Asia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 58: South Asia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 59: South Asia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 60: South Asia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 61: South Asia Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)

Figure 62: South Asia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 63: South Asia Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 64: South Asia Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 65: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 66: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030

Figure 67: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 68: South Asia Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030

Figure 69: East Asia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 70: East Asia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 71: East Asia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 72: East Asia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 73: East Asia Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)

Figure 74: East Asia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 75: East Asia Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 76: East Asia Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 77: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 78: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030

Figure 79: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 80: East Asia Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030

Figure 81: Oceania Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 82: Oceania Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 83: Oceania Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 84: Oceania Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 85: Oceania Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)

Figure 86: Oceania Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 87: Oceania Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 88: Oceania Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 89: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 90: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030

Figure 91: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 92: Oceania Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030

Figure 93: MEA Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 94: MEA Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 95: MEA Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 96: MEA Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 97: MEA Biological and Chemical Indicators Market Value Share, By Country, 2022 (E)

Figure 98: MEA Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2015-2021

Figure 99: MEA Biological and Chemical Indicators Market Value Forecast (US$ Mn), 2022-2030

Figure 100: MEA Biological and Chemical Indicators Market Attractiveness Analysis, By Sterilization Type, 2022-2030

Figure 101: MEA Biological and Chemical Indicators Market Attractiveness Analysis by Indicator Class, 2022-2030

Figure 102: MEA Biological and Chemical Indicators Market Attractiveness Analysis by Packaging Form, 2022-2030

Figure 103: MEA Biological and Chemical Indicators Market Attractiveness Analysis by End User, 2022-2030

Figure 104: MEA Biological and Chemical Indicators Market Attractiveness Analysis by Country, 2022-2030

Figure 105: U. S. Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 106: U. S. Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 107: U. S. Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 108: U. S. Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 109: U. S. Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 110: Canada Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 111: Canada Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 112: Canada Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 113: Canada Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 114: Canada Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 115: Brazil Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 116: Brazil Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 117: Brazil Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 118: Brazil Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 119: Brazil Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 120: Mexico Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 121: Mexico Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 122: Mexico Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 123: Mexico Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 124: Mexico Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 125: U. K. Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 126: U. K. Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 127: U. K. Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 128: U. K. Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 129: U. K. Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 130: Germany Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 131: Germany Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 132: Germany Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 133: Germany Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 134: Germany Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 135: France Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 136: France Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 137: France Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 138: France Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 139: France Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 140: Italy Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 141: Italy Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 142: Italy Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 143: Italy Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 144: Italy Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 145: Spain Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 146: Spain Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 147: Spain Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 148: Spain Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 149: Spain Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 150: Russia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 151: Russia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 152: Russia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 153: Russia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 154: Russia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 155: China Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 156: China Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 157: China Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 158: China Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 159: China Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 160: Japan Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 161: Japan Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 162: Japan Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 163: Japan Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 164: Japan Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 165: South Korea Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 166: South Korea Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 167: South Korea Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 168: South Korea Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 169: South Korea Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 170: India Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 171: India Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 172: India Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 173: India Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 174: India Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 175: Indonesia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 176: Indonesia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 177: Indonesia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 178: Indonesia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 179: Indonesia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 180: Australia Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 181: Australia Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 182: Australia Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 183: Australia Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 184: Australia Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 185: New Zealand Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 186: New Zealand Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 187: New Zealand Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 188: New Zealand Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 189: New Zealand Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 190: GCC Countries Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 191: GCC Countries Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 192: GCC Countries Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 193: GCC Countries Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 194: GCC Countries Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 195: Turkey Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 196: Turkey Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 197: Turkey Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 198: Turkey Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 199: Turkey Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Figure 200: South Africa Biological and Chemical Indicators Market Value Share, By Sterilization Type, 2022 (E)

Figure 201: South Africa Biological and Chemical Indicators Market Value Share, By Indicator Class, 2022 (E)

Figure 202: South Africa Biological and Chemical Indicators Market Value Share, By Packaging Form, 2022 (E)

Figure 203: South Africa Biological and Chemical Indicators Market Value Share, By End User, 2022 (E)

Figure 204: South Africa Biological and Chemical Indicators Market Value Analysis (US$ Mn), 2022 & 2030

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Aesthetic Medicine And Cosmetic Surgery Market

Published : April 2017

Healthcare

Veterinary Biologicals Biobank Market

Published : April 2017

Healthcare

Cancer Biological Therapy Market

Published : November 2016

Google translate

Biological and Chemical Indicators Market